Carole A. Sable
Directeur Technique/Scientifique/R&D chez VITAE PHARMACEUTICALS INC
Postes actifs de Carole A. Sable
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| VITAE PHARMACEUTICALS INC | Directeur Technique/Scientifique/R&D | 06/06/2016 | - |
| BASILEA PHARMACEUTICA AG | Directeur/Membre du Conseil | 27/04/2023 | - |
Historique de carrière de Carole A. Sable
Anciens postes connus de Carole A. Sable
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SCYNEXIS, INC. | Directeur Technique/Scientifique/R&D | 01/01/2014 | 20/02/2015 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/01/2010 | 01/01/2013 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/01/1995 | 01/01/2007 |
| University of Virginia | Corporate Officer/Principal | 01/01/1993 | 01/01/1995 |
| REVOLUTION MEDICINES, INC. | Directeur Technique/Scientifique/R&D | 05/03/2015 | - |
Novexel SA
 Novexel SA Pharmaceuticals: MajorHealth Technology Novexel SA researches and develops anti-infective drugs for the treatment of bacterial and fungal infections. The firm focuses on discovery and development of novel antibiotics designed to overcome the significant global problem of microbial resistance. The company was founded in December 2004 and is headquartered in Romainville, France. | Directeur Technique/Scientifique/R&D | - | - |
Formation de Carole A. Sable
| Sidney Kimmel Medical College | Doctorate Degree |
| Thomas Jefferson University | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 8 |
| France | 2 |
| Suisse | 2 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 4 |
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 2 |
Sectorielle
| Health Technology | 7 |
| Consumer Services | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| SCYNEXIS, INC. | Health Technology |
| REVOLUTION MEDICINES, INC. | Health Technology |
| BASILEA PHARMACEUTICA AG | Health Technology |
| Entreprise privées | 2 |
|---|---|
Novexel SA
Novexel SA Pharmaceuticals: MajorHealth Technology Novexel SA researches and develops anti-infective drugs for the treatment of bacterial and fungal infections. The firm focuses on discovery and development of novel antibiotics designed to overcome the significant global problem of microbial resistance. The company was founded in December 2004 and is headquartered in Romainville, France. | Health Technology |
Vitae Pharmaceuticals LLC
 Vitae Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vitae Pharmaceuticals LLC is a clinical-stage bio-pharmaceutical company, which engages in discovering and developing novel, small molecule drugs for diseases, including chronic kidney disease, diabetes and Alzheimer's disease, and autoimmune disorders, acute coronary syndrome, and immuno-oncology. The company was founded by John J. Baldwin, Bartosz A. Grzybowski, George M. Whitesides, and Eugene Shakhnovich on May 21, 2001 and is headquartered in Fort Washington, PA. | Health Technology |
- Bourse
- Insiders
- Carole A. Sable
- Expérience
